Angiogenesis: A new prognostic marker for breast cancer

British Journal of Biomedical Science

Volumn 55, Issue 3, 1998, Pages 214-220

  Magennis, D P ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast neoplasms; Neovascularization; Pathologic; Prognosis

Indexed keywords

ANGIOGENESIS; BREAST CARCINOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0031755815     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Ogawa Y, Chung Y-S, Nakata B et al. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antibody. Br J Cancer 1995; 71:1297-301.
2. McGuire WL. Adjuvant therapy of node-negative breast cancer. N Engl J Med 1989; 320:525-7.
3. Folkman J. Diagnostic and therapeutic applications of angiogenesis research. C R Acad Sci Paris III 1993; 316:914-18.
4. Wagner RC. Endothelial cell embryology and growth. Adv Microcirc 1980; 9:45-75.
5. Hunt TK. Wound repair and wound infection: theory and surgical practice. New York, NY: Appleton Century Crofts, 1980.
6. Folkman J. Tumour angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182-6.
7. Hobson B, Denekamp J. Endothelial proliferation in tumours and normal tissue: continuous labelling studies. Br J Cancer 1984; 49:405-13.
8. Dvorak HF, Nagy AJ, Dvorak AM. Structure of solid tumours and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 1991; 3:77-85.
9. Gimbrone MA, Leapman SB, Cotran RS, Folkman J. Tumour dormancy in vivo by prevention of neovascularisation. J Exp Med 1972; 136:261-76.
10. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
11. Weidner N. Intratumour microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147:9-19.
12. Nicosia RF, Tchao R, Leighton J. Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin Exp Metastasis 1986; 4:91-104.
13. Rak JW, Hegmann EJ, Lu C, Kerbel RS. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. J Cell Physiol 1994; 159:245-55.
14. Hamada J, Cavanaugh PG, Lotan O. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Dr J Cancer 1992; 66:349-54.
15. Folkman J. Angiogenesis in breast cancer. J Clin Oncol 1994; 12:441-3.
16. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastasis. Adv Cancer Res 1978; 28:149-250.
17. Weidner N. Tumour angiogenesis: review of current applications in tumour prognostication. Semin Diagn Pathol 1993; 10:302-13.
18. Liotta LA, Kleinerman J, Saidel G. The significance of hematogenous tumour cell clumps in the metastatic process. Cancer Res 1976; 36:889-94.
19. Moscatelli D, Gross J, Rifkin D. Angiogenic factors stimulate plasminogen activator and collagenase production by capillary endothelial cells. J Cell Biol 1981; 91:201a.
20. Brem S, Cotran R, Folkman J. Tumour angiogenesis: a quantitative method for histological grading. J Natl Cancer Inst 1972; 48:347-56.
21. Srivastava A, Laidler P, Davies RP, Horan K, Hughes LE. The prognostic significance of tumour vascularity in intermediate thickness (0.74-1.0 mm thick) skin melanoma. Am J Pathol 1988; 133:419-23.
22. Weidner N, Semple SP, Welch WR, Folkman J. Tumour angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.